CD19-directed Chimeric Antigen Receptor drugs

2 medications in the FDA established pharmacologic class “CD19-directed Chimeric Antigen Receptor”.

DrugTypeNDC products
Kymriah
tisagenlecleucel		Rx2
Yescarta
axicabtagene ciloleucel		Rx1